Diane J. Lewis-D’Agostino
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Sexual function and dysfunction studies, Sexuality, Behavior, and Technology, Diabetes Treatment and Management, Diabetes Management and Research, Hormonal and reproductive studies
Most-Cited Works
- → Validation of the Female Sexual Distress Scale-Revised for Assessing Distress in Women with Hypoactive Sexual Desire Disorder(2007)723 cited
- → Validation of the Decreased Sexual Desire Screener (DSDS): A Brief Diagnostic Instrument for Generalized Acquired Female Hypoactive Sexual Desire Disorder (HSDD)(2009)182 cited
- → Reliability and Validity of the Sexual Interest and Desire Inventory–Female (SIDI-F), a Scale Designed to Measure Severity of Female Hypoactive Sexual Desire Disorder(2006)158 cited
- → Validation of the Sexual Interest and Desire Inventory-Female in Hypoactive Sexual Desire Disorder(2010)49 cited
- → Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with Type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24‐week randomized, double‐blind study(2014)45 cited
- → Validity of the Decreased Sexual Desire Screener for Diagnosing Hypoactive Sexual Desire Disorder(2012)31 cited
- → Cutoff Score of the Sexual Interest and Desire Inventory-Female for Diagnosis of Hypoactive Sexual Desire Disorder(2010)28 cited
- → Efficacy and safety of linagliptin to improve glucose control in older people with type 2 diabetes on stable insulin therapy: A randomized trial(2019)27 cited
- → eDiary and Female Sexual Distress Scale©in Evaluating Distress in Hypoactive Sexual Desire Disorder (HSDD)(2010)24 cited
- → Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double‐blind, active‐controlled, parallel group, multinational clinical trial(2014)22 cited